tradingkey.logo

Smith & Nephew PLC

SNN
View Detailed Chart
36.780USD
+0.250+0.68%
Market hours ETQuotes delayed by 15 min
16.11BMarket Cap
--P/E TTM

Smith & Nephew PLC

36.780
+0.250+0.68%
Intraday
1m
30m
1h
D
W
M
D

Today

+0.68%

5 Days

+4.31%

1 Month

-0.19%

6 Months

+43.11%

Year to Date

+49.63%

1 Year

+25.23%

View Detailed Chart

TradingKey Stock Score of Smith & Nephew PLC

Currency: USD Updated: 2025-10-21

Key Insights

The company's fundamentals are relatively healthy. Its valuation is considered undervalued,and institutional recognition is very high. Over the past 30 days, multiple analysts have rated the company as a Buy. Despite an average stock market performance, the company shows strong fundamentals and technicals. The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Smith & Nephew PLC's Score

Industry at a Glance

Industry Ranking
60 / 204
Overall Ranking
136 / 4687
Industry
Healthcare Equipment & Supplies

Support & Resistance

No Data

Score Analysis

Current score
Previous score

Analyst Rating

Based on 4 analysts
Buy
Current Rating
35.157
Target Price
-3.23%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Smith & Nephew PLC Highlights

StrengthsRisks
Smith & Nephew plc is a portfolio medical technology company. The Company is engaged in developing, manufacturing, marketing, and selling medical devices and services. It is focused on the repair, regeneration, and replacement of soft and hard tissue. Its segments include Orthopaedics, Sports Medicine & ENT and Advanced Wound Management. Its Orthopaedics segment includes a range of hip and knee Implants used to replace diseased, damaged or worn joints, robotics-assisted and digital enabling technologies and services that help surgeons, and trauma products used to stabilize severe fractures and correct hard tissue deformities. Its Sports Medicine & Ear, Nose and Throat (ENT) businesses offer advanced products and instruments used to repair or remove soft tissue. Its Advanced Wound Management portfolio provides a comprehensive set of products to meet broad and complex clinical needs, and to help healthcare professionals reduce the human and economic consequences of wounds.
High Profit Growth
The company's net income leads the industry, with the latest annual income totaling USD 5.81B.
High Dividend
The company is a high dividend payer, with the latest dividend payout ratio of 79.37%.
Stable Dividend
The company has regularly paid dividends over the past 5 years, with the latest dividend payout ratio of 79.37%.
Overvalued
The company’s latest PE is 32.50, at a high 3-year percentile range.
Institutional Selling
The latest institutional holdings are 33.01M shares, decreasing 26.26% quarter-over-quarter.
Held by Brandes Investmen
Star Investor Brandes Investmen holds 1.60M shares of this stock.

News

More news coming soon, stay tuned...

Financial Indicators

EPS

No Data

Total revenue

No Data

Smith & Nephew PLC Info

Smith & Nephew plc is a portfolio medical technology company. The Company is engaged in developing, manufacturing, marketing, and selling medical devices and services. It is focused on the repair, regeneration, and replacement of soft and hard tissue. Its segments include Orthopaedics, Sports Medicine & ENT and Advanced Wound Management. Its Orthopaedics segment includes a range of hip and knee Implants used to replace diseased, damaged or worn joints, robotics-assisted and digital enabling technologies and services that help surgeons, and trauma products used to stabilize severe fractures and correct hard tissue deformities. Its Sports Medicine & Ear, Nose and Throat (ENT) businesses offer advanced products and instruments used to repair or remove soft tissue. Its Advanced Wound Management portfolio provides a comprehensive set of products to meet broad and complex clinical needs, and to help healthcare professionals reduce the human and economic consequences of wounds.
Ticker SymbolSNN
CompanySmith & Nephew PLC
CEOMr. Deepak S. Nath
Websitehttps://www.smith-nephew.com/
KeyAI